The Lancet Oncology

Lancet Oncol

1470-2045

1474-5488

Therapeutic Area

Hematology, Oncology

Biomedical Researchers, Clinicians, Oncologists, Policy Makers, Researchers

The Lancet Oncology was launched in September, 2000, as a lively and informative monthly journal covering international issues relevant to clinical cancer specialists worldwide. The journal is now the world-leading clinical oncology periodical publishing high-quality, peer-reviewed research (especially reports from clinical trials), reviews, comment and opinion, weekly news, and Commissions (typically in partnership with societies, governments, NGOs, and academic centres). Content covers topics that advance clinical practice, challenge the status quo, advocate change in health policy, and tackle issues related to global oncology. Much of the journal’s articles are published Online First for enhanced timeliness prior to print publication. Uniquely, all original research is peer-reviewed via a fast-track service, and successful papers are published within 8 weeks of submission. The journal also regularly features podcasts, video, infographics, and curated web content. The Lancet Oncology has also fostered a reputation for hosting events for oncologists, cancer researchers, and policymakers. The Lancet Oncology convenes many conferences, either alone or in collaboration with partners. Events include branded plenary lectures and sessions at conferences worldwide; the long-running Asian Oncology Summit series; Oncology At The Limits; Frontiers of Oncology; Advancing Cancer Immunotherapy; and The Lancet Summit, to name just a few.

No associations affiliated with this journal

Elsevier Inc - NY

Impact Factor JCR Categories/Rank Circulation Electronic Circulation Submission to Acceptance Acceptance to Online Publication Acceptance to Print Publication Rejection Rate Frequency Journal Contact Author Submission Guidelines